1Chan LY,Tam WH,Lau TK.Venous thromboembolism in pregnant Chinese women[J].Obstet Gynecol,2001,98 (3):471 -475.
2Bonnar J.Can more be done in obstetric and gynecologic practice to reduce morbidity and mortality associated with venous thromboembolism ?[J].Am J Obstet Gynecol,1999,180(4):784-791.
5Bowles L,Cohen H.Inherited thrombophilias and anti-coagulation in pregnancy[J].Best Pract Res Clin Obstet Gynaecol,2003,17(3):471-489.
6Tomialowicz M,Florjanski J,Zimmer M,et al.Assessment of the effectiveness of using low molecular weight heparin in the prophylaxis of venous thrombo-embolic diseases in obstetrics[J].Ginekol Pol,2000,71 (9):1115-1119.
7Dulitzki M,Pauzner R,Langevitz P,et al.Low-molecular-weight heparin during pregnancy and delivery:preliminary experience with 41 pregnancies[J].Obstet Gynecol,1996,87 (3):380-383.
8Andres RL,Miles A.Venous thromboembolism and pregnancy[J].Obstet Gynecol Clin North Am,2001,28(3):613-630.
1[1]Lensen R, Rosendal F, Koster T, et al. Apparent different thrombotic tendency in patients with factor Ⅴ Leiden and protein C deficiency due to selection of patients. Blood, 1996,88:4205-4208.
2[2]Arkel YS,Ku DH. Thrombophilia and pregnancy:review of the literature and some originaldata. Clin Appl Thromb Hemost,2001,7: 259-68.
3[3]McColl MD, Ramsay JE, Tait RC, Risk factors for pregnancy associated venous thromboembolism. Thrombosis and Haemostasis, 1997,78:1183-1188.
4[4]Pabinger Ⅰ , SchneiderB. Thrombotic risk in hereditary antithrombin Ⅲ, protein C and Protein S deficiency. A cooperative retrospective study. Arteriosclerosis Thrombosis and Vasculariology, 1996,16: 742-748.
5[5]De Stefano V, Leone G, Mastrangelo S, et al. Thrombosis during pregnancy and surgery in patients with congenital deficiency of antithrombin Ⅲ, protein C and Protein S. thrombosis and Haemostasis, 1994,71: 799-800.
6[6]Hellgren M, Svensson P, Dahlback B. Resistance to activated protein C is a basis for venous thromboembolism associated with pregnancy and oral contraceptives. American Journal of Journal of Obstetrics and Gynecology, 1995,173:210-213.
7[7]Rosendaal FR. Risk factors for venous thrombotic disease.Thrombosis and Haemostasis, 1999,82: 616-619.
8[8]Simmonds RE, Zoller B, Ireland H, et al. Genetic and phenotypic analysis of a large(122 member) protein S deficient kindred provides an explanation for the familial coexistence of type Ⅰ and type Ⅲ plasma phenotypes, Blood, 1997,89: 4364-4370.
9[9]Chan WS,Ginsberg J. Management of venous thromboembolism in pregnancy. In: Oudkerk M, van Beek EJR, ten Cate JW (eds). Pulmonary embolism. Blackwell Wissenschaft Berlin Vienna 1999: 430-437.
10[10]Bertina RM, Reitsma PH, Rosendaal FR & Vandenbroucke JP. Resistance to activated protein C and FV Leiden as risk factors for venous thrombosis. Thrombosis and Haemostasis,1995,74: 449-453.
